Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

44.19
+2.776.69%
Post-market: 44.190.00000.00%19:37 EDT
Volume:2.89M
Turnover:125.83M
Market Cap:5.51B
PE:-13.21
High:44.84
Open:41.93
Low:41.19
Close:41.42
Loading ...

Stock Track | Guardant Health Soars 5% After Piper Sandler Reiterates Buy Rating

Stock Track
·
11 hours ago

Stock Track | Guardant Health Soars 5% as Piper Sandler Reaffirms Buy Rating

Stock Track
·
11 hours ago

Guardant Health (GH) Receives a Buy from Piper Sandler

TIPRANKS
·
Yesterday

GH Research PLC Approves Key Resolutions at Annual Meeting

TIPRANKS
·
01 Aug

Stock Track | Guardant Health Plummets 10.25% Despite Strong Q2 Results and Raised Guidance

Stock Track
·
01 Aug

Guardant Health Inc. to Participate in Canaccord Genuity 45th Annual Growth Conference in Boston

Reuters
·
01 Aug

Guardant Health Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
01 Aug

Raymond James Reaffirms Their Buy Rating on Guardant Health (GH)

TIPRANKS
·
01 Aug

Guardant Health price target raised to $60 from $57 at Scotiabank

TIPRANKS
·
31 Jul

Stock Track | Guardant Health Plummets 5.29% Despite Strong Q2 Results and Analyst Upgrades

Stock Track
·
31 Jul

Guardant Health Inc : Leerink Partners Raises Target Price to $70 From $65

THOMSON REUTERS
·
31 Jul

Guardant Health Inc : Scotiabank Raises Target Price to $60 From $57

THOMSON REUTERS
·
31 Jul

Guardant Health Inc. Management Discusses Q2 2025 Financial Results in Conference Call

Reuters
·
31 Jul

Stock Track | Guardant Health Soars 5.66% After-Hours on Q2 Earnings Beat and Raised Guidance

Stock Track
·
31 Jul

Guardant Health Q2 Adjusted EPS USD -0.44 Vs. IBES Estimate USD -0.79

Reuters
·
31 Jul

Guardant Health Q2 Adj. EPS $(0.44) Beats $(0.79) Estimate, Sales $232.09M Beat $211.26M Estimate

Benzinga
·
31 Jul

Guardant Health Unveils Promising Results from RADIOHEAD Study, Highlighting Early Detection of Immunotherapy Response in Advanced Cancer Patients

Reuters
·
29 Jul

GH Research (GHRS) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
29 Jul

GH Research’s Strategic Path Forward: Overcoming Regulatory Hurdles and Capitalizing on Market Opportunities

TIPRANKS
·
24 Jul

TD Cowen Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
24 Jul